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ABSTRACT 15 
Perfluorooctanesulfonic acid (PFOS) is a ubiquitous environmental contaminant, previously 16 
utilized as a non-stick application for consumer products and firefighting foam. It can cross the 17 
placenta, and has been repeatedly associated with increased risk for diabetes in epidemiological 18 
studies. Here, we sought to establish the hazard posed by embryonic PFOS exposures on the 19 
developing pancreas in a model vertebrate embryo, and develop criteria for an adverse outcome 20 
pathway (AOP) framework to study the developmental origins of metabolic dysfunction. 21 
Zebrafish (Danio rerio) embryos were exposed to 16, 32, or 64 µM PFOS beginning at the mid-22 
blastula transition. We assessed embryo health, size, and islet morphology in Tg(insulin-GFP) 23 
embryos at 48, 96 and 168 hpf, and pancreas length in Tg(ptf1a-GFP) embryos at 96 and 168 24 
hpf. QPCR was used to measure gene expression of endocrine and exocrine hormones, digestive 25 
peptides, and transcription factors to determine whether these could be used as a predictive 26 
measure in an AOP. Embryos exposed to PFOS showed anomalous islet morphology and 27 
decreased islet size and pancreas length in a U-shaped dose-response curve, which resemble 28 
congenital defects associated with increased risk for diabetes in humans. Expression of genes 29 
encoding islet hormones and exocrine digestive peptides followed a similar pattern, as did total 30 
larval growth. Our results demonstrate that embryonic PFOS exposures can disrupt pancreatic 31 
organogenesis in ways that mimic human congenital defects known to predispose individuals to 32 
diabetes; however, future study of the association between these defects and metabolic 33 
dysfunction are needed to establish an improved AOP framework. 34 
 35 
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 37 
Capsule: Aberrant pancreas development is a novel hazard of embryonic PFOS exposures  38 
 39 
Highlights: 40 
• Developmental PFOS exposures decreased the size of beta cell mass in the primary Islet of 41 
Langerhans in the zebrafish embryo. 42 
• PFOS exposures increased the incidence of islet malformations and shortened pancreas length, 43 
which recapitulate congenital defects known to increase risk for diabetes in humans.  44 
• Abnormal pancreas development is a previously unidentified hazard of developmental PFOS 45 
exposures. 46 
 47 
 48 
 49 
  50 
INTRODUCTION 51 
The global prevalence of diabetes has been rapidly increasing in recent decades (National 52 
Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), 2014). Both Type 1 and Type 53 
2 diabetes manifest as hyperglycemia related to reduced beta cell mass, either due to 54 
autoimmune destruction of the insulin-producing beta cells in Type 1, or insulin resistance with 55 
loss of beta cell mass in Type 2 diabetes. Recent studies have demonstrated that chemical 56 
exposures are capable of reducing beta cell mass. However, the consequences of developmental 57 
exposures on the rapidly growing and maturing islets require identification.  58 
While genetic sources of metabolic dysregulation are known to contribute to diabetic 59 
etiology in the adult, there is a growing body of evidence supporting the link between 60 
developmental environmental exposures and occurrence of diabetes later in life (Inadera, 2013; 61 
Simmons, 2006; Simmons, 2007). Numerous studies have investigated how physiological and 62 
pharmacological conditions influence beta cell health in adolescents and adults; however, very 63 
little is known about how these conditions may impact the sensitive developing pancreas, and 64 
whether these developmental consequences may manifest as metabolic dysfunction in adulthood. 65 
These gaps in our knowledge warrant investigation to produce a robust, predictive adverse 66 
outcome pathway (AOP) to study the developmental origins of diabetes and metabolic disease. 67 
Islet architecture plays an important role in the governance of islet physiology and 68 
endocrinology, and variant morphologies can be observed concurrent with diabetic phenotypes 69 
and hyperglycemia (Bosco et al., 2010; Cabrera et al., 2006; Kilimnik et al., 2011; Kim et al., 70 
2009). An increased risk of metabolic disease and pancreatitis has been associated with four 71 
congenital pancreatic malformations found in the human population: pancreas divisum, ectopic 72 
pancreatic tissue, dorsal pancreatic agenesis, and annular pancreas. Pancreas divisum and ectopic 73 
pancreatic tissue are predicted to occur in approximately 10% of the population (Prasad et al., 74 
2001; Varshney and Johnson, 1999; Vaughn et al., 1998), while the other two anomalies are 75 
considered rare. Unlike most congenital defects which manifest as life-threatening or debilitating 76 
conditions, these pancreatic defects result in largely mild phenotypic outcomes and thus often go 77 
undetected, although they have been associated with increased risk for diabetes and pancreatitis 78 
in adulthood (Balakrishnan et al., 2006; Concepcion et al., 2014; Gentile and Fiorente, 1999; 79 
Gilinsky et al., 1987; Lindstrom et al., 1990; Mitchell et al., 2004; Shoji et al., 2013). The causes 80 
of these malformations are largely unknown, but do not appear to be genetic in nature. This 81 
suggests that these congenital pancreatic defects occur in response to environmental stimuli. 82 
Pancreas development is difficult to observe during embryonic development in 83 
mammalian models, as it requires highly invasive procedures. Building upon an understanding of 84 
highly conserved vertebrate developmental processes, the zebrafish embryo is a well-established 85 
model for studying pancreas development (reviewed in (Kinkel and Prince, 2009; Tiso et al., 86 
2009)). Because zebrafish embryos are transparent and fertilized externally, this allows for direct 87 
visualization of developing pancreas structures throughout the developmental timecourse. 88 
Both the endocrine and exocrine pancreas can be easily visualized during organogenesis 89 
using transgenic zebrafish models (Tiso et al., 2009). The pancreas is formed from two anlages 90 
that emerge from the endoderm and fuse together and extend dorsally during organogenesis. The 91 
endocrine pancreas houses the islets of Langerhans, which largely consist of the insulin-92 
producing beta cells, but also include other cell types that secrete hormones that regulate nutrient 93 
metabolism and comprise the glucose homeostasis feedback system. These include alpha cells 94 
that produce glucagon, delta cells that produce somatostatin, epsilon cells that produce ghrelin, 95 
and gamma cells (also called pancreatic polypeptide cells) that produce pancreatic polypeptide. 96 
The islets are embedded in the exocrine pancreas tissue, which functions to produce digestive 97 
enzymes that drain into ducts feeding into the duodenum. Transgenic zebrafish, such as those 98 
engineered to express fluorescent proteins in beta cells (Tg(ins:GFP)) and in the exocrine 99 
pancreas tissue (Tg(ptf1a:GFP)) (diIorio et al., 2002; Lin et al., 2004), present a unique 100 
opportunity to study the effects of toxicant exposures on this sensitive target tissue in a live 101 
vertebrate embryo in real time, and determine the relationship between toxicant exposures and 102 
pancreatic defects.   103 
One anthropogenic contaminant that might contribute to pancreatic malformations is 104 
perfluorooctanesulfonic acid (PFOS), which has been repeatedly associated with metabolic 105 
dysfunction. PFOS is a surfactant previously found in non-stick application products, such as 106 
Teflon and Scotchgard, until it was phased out of production in the United States in 2002. It is 107 
highly persistent in the environment and in the body, with a half-life of approximately 5 years in 108 
human serum (Olsen et al., 2007), though estimated to be roughly 12 days in the blood of 109 
rainbow trout (Martin et al., 2003). Humans are almost ubiquitously exposed to PFOS, which has 110 
been detected in >98% of human serum samples (Calafat et al., 2007) and also found in human 111 
pancreas tissue (Maestri et al., 2006). Detection in both cord blood and amniotic fluid samples 112 
demonstrates that PFOS can also cross the placental barrier, indicating an exposure risk to the 113 
developing fetus (Inoue et al., 2004; Toft et al., 2016). Numerous studies have  associated PFOS 114 
exposures with markers for metabolic syndrome and diabetes, such as elevated insulin and 115 
cholesterol, insulin resistance, and altered beta cell function (Lin et al., 2009; Lv et al., 2013; 116 
Nelson et al., 2010; Wan et al., 2014). However, the pathological consequences of PFOS 117 
exposure for the fetal pancreas, as well as the underlying mechanism of PFOS-induced metabolic 118 
dysfunction, remain unknown. 119 
Our study objective was to identify whether embryonic exposure to PFOS may alter the 120 
structure and function of the developing pancreas.  We hypothesized that embryonic PFOS 121 
exposures would reduce β cell mass and disrupt the glucoregulatory axis. Here, we utilize the 122 
zebrafish embryo model to visualize malformations of the developing pancreas, and develop 123 
criteria for use in an AOP to interrogate the developmental origins of metabolic dysfunction.  124 
 125 
MATERIALS & METHODS 126 
CHEMICALS 127 
Heptadecafluorooctanesulfonic acid (PFOS) was purchased from Sigma-Aldrich (St. 128 
Louis, MO). Dimethyl sulfoxide (DMSO) was purchased from Fisher Scientific (Pittsburgh, PA). 129 
Stock solutions [160-640 mM] for embryo exposures were prepared by dissolving PFOS into 130 
DMSO, and stored at room temperature in glass bottles inside of light-prohibitive containers 131 
until use. All experimental procedures involving PFOS were performed using appropriate safety 132 
precautions.  133 
 134 
ANIMALS AND HUSBANDRY 135 
 Transgenic zebrafish of the Tg(ins:GFP) (diIorio et al., 2002) and Tg(ptf1a:GFP) strains 136 
were each obtained as a heterozygous population from Dr. Philip diIorio at the University of 137 
Massachusetts Medical School (Worchester, MA) and bred in house to homozygosity. The 138 
Tg(ins-GFP) strain expresses green fluorescence in the insulin-producing beta cells, allowing for 139 
visualization of pancreatic islets. The Tg(ptf1a:GFP) strain expresses green fluorescence in the 140 
exocrine pancreas tissues, and also in the retina and parts of the brain (Godinho et al., 2005; Lin 141 
et al., 2004). 142 
 Adult fish were housed in an Aquaneering zebrafish system maintained at 28.5°C in 143 
accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals 144 
of the National Institutes of Health and with approval from the University of Massachusetts 145 
Amherst Institutional Animal Care and Use Committee (Animal Welfare Assurance Number 146 
A3551-01). Fish were maintained on a 14 h light:10 h dark daily cycle, and provided the 147 
recommended amount of GEMMA Micro 300 (Skretting; Westbrook, ME) once daily. Breeding 148 
populations were housed in tanks containing roughly 15 males and 30 females.  149 
 Embryos were collected from breeding tanks 0-1 hour post fertilization (hpf), washed, 150 
and housed with no more than 25 other embryos in glass 100 mm petri dishes containing 0.3X 151 
Danieau’s medium (17 mM NaCl, 2 mM KCl, 0.12mM MgSO4, 1.8mM Ca(NO3)2, 1.5mM 152 
HEPES, pH 7.6) throughout the experiments.  153 
 154 
EXPOSURES 155 
 At 3 hours post fertilization (hpf), embryos staged at the mid-blastula transition were 156 
exposed to PFOS solutions with a total of 0.01% DMSO v/v in a total of 20 ml of 0.3X 157 
Danieau’s medium. Final concentrations of PFOS were 0 (DMSO control), 16, 32, or 64 µM, 158 
and were refreshed daily to mimic subchronic developmental exposures. These concentrations 159 
were chosen based upon exposures used in other zebrafish studies (Chen et al., 2014; Wang et 160 
al., 2011; Zheng et al., 2011), and to optimize islet effects while minimizing effects on gross 161 
anatomy and embryo survival. All embryos were manually dechorionated using watchmaker’s 162 
forceps at 24 hpf and debris removed from dishes prior to refreshing exposures. Experiments 163 
were replicated 3-4 times on groups of 8-12 embryos per concentration. 164 
 165 
MICROSCOPY 166 
 Tg(ins-GFP) embryos and larvae were imaged at 48, 96, and 168 hpf to observe 167 
morphogenesis of the primary islet, and later formation of the secondary islets. Tg(ptf1a-GFP) 168 
larvae were imaged at 96 and 168 hpf to observe the extension of the exocrine pancreas, 169 
indicative of total pancreas length. All imaging was performed using an inverted fluorescence 170 
microscope (EVOS FL Auto, Life Technologies, Pittsburgh, PA) equipped with a GFP filter. 171 
Embryos and larvae were washed thoroughly and briefly anaesthetized in 2% v/v MS-222 172 
solution (prepared as 4 mg/ml tricaine powder in water, pH buffered, and stored at -20°C until 173 
use). Embryos and larvae were mounted in drops of 3% methylcellulose for imaging, and 174 
oriented for optimal pancreas visualization. Images were acquired using 10X and 20X objectives 175 
for magnification of islets, and 4X magnification for exocrine pancreas visualization. Because 176 
images were obtained on an inverted microscope, images presented in figures have been mirror-177 
flipped to reflect the actual orientation. 178 
 179 
RNA ISOLATION AND REVERSE TRANSCRIPTION 180 
RNA was collected from embryos at 48 hpf and 96 hpf for targeted examination of 181 
pancreas-relevant gene expression. Embryos were collected into RNAlater (Fisher Scientific) 182 
and stored at -80°F until RNA isolation. At 48 hpf, 8-10 embryos were pooled per sample for a 183 
total of 6-9 samples per exposure group; at 96 hpf, 5-7 eleutheroembryos were pooled per sample 184 
for a total of 4-5 samples per exposure group. Eleutheroembryos are those that have hatched, but 185 
are not yet independently feeding and are still dependent on their yolk for nutrition. 186 
Samples were processed with the GeneJET RNA Purification Kit (Fisher Scientific; 187 
Waltham, MA) according to manufacturer instructions. RNA concentrations were determined 188 
using a BioDrop µLITE spectrophotometer (BioDrop; Cambridge, UK). For 48 hpf samples, 500 189 
ng RNA underwent reverse transcription for cDNA conversion using the iScript cDNA Synthesis 190 
Kit (Bio-Rad). For 96 hpf samples, 1 µg of RNA was reverse transcribed into cDNA. Upon 191 
completion, cDNA was stored at -20°C until use. 192 
 193 
QUANTITATIVE PCR 194 
 Prior to qPCR, cDNA was diluted to a working stock of 0.25 ng/µl for use in reactions. 195 
Quantitative PCR was performed using a Bio-Rad CFX Connect Real-Time PCR Detection 196 
System in a 20 µl reaction mixture containing 10 µl 2x iQ SYBR Green Supermix (Bio-Rad), 5 197 
pM of each primer, 5 µl water, and 1 ng (4 µl) of cDNA template. Primers used in this study 198 
have been previously published (Timme-Laragy et al., 2015). Previously designed and optimized 199 
primers for β-actin (actb), beta-2-macroglobulin (b2m), and preproinsulin a (insa) are provided 200 
in Supplementary Table 1. Endocrine pancreas gene expression was investigated at 48 and 96 201 
hpf using commercially available PrimePCR primers (Bio-Rad) for pancreatic and duodenal 202 
homeobox 1 (pdx1), somatostatin 2 (sst2), glucagon a (gcga), and ghrelin (ghrl). Exocrine 203 
pancreas gene expression was examined at 96 hpf using PrimePCR primers for pancreas specific 204 
transcription factor 1a (ptf1a), trypsin (try), chymotrypsinogen B1 (ctrb1), and pancreatic 205 
amylase 2a (amy2a). Data was visualized and analyzed using the Bio-Rad CFX Manager 206 
software, and fold-changes were calculated using the ΔΔCT method (Livak and Schmittgen, 207 
2001). Treatment did not significantly affect the expression the housekeeping genes, actb or 208 
b2m, and all fold changes were standardized relative to actb expression. 209 
 210 
STATISTICAL ANALYSIS 211 
 All data is presented as the mean ± SEM. Independent t-tests and ANOVAs were used to 212 
test for statistical significance using IBM SPSS software. Fisher’s Exact Test was used to test for 213 
significant differences in the prevalence of secondary islets and islet morphological variants. A 214 
confidence level of 95% (α=0.05) was used. 215 
 216 
RESULTS 217 
ISLET SIZE 218 
 Diabetic phenotypes are often characterized by decreased beta cell mass [reviewed in 219 
(Akirav et al., 2008; Karaca et al., 2009; Matveyenko and Butler, 2008)]. To assess whether 220 
PFOS exposures could reduce beta cell mass during development, we measured area of the beta 221 
cells labeled with GFP driven by the insulin promoter. Primary islet size was quantified for 222 
embryos at 48 hpf and eleutheroembryos at 96 hpf, a time point previously shown to be sensitive 223 
to toxicological perturbation of pancreatic organogenesis (Timme-Laragy et al., 2015). At 48 224 
hpf, islet area decreased following a non-monotonic response (Fig. 1). A decrease of islet area 225 
was observed for 16 and 32 µM PFOS exposures compared to controls, though there was a 226 
moderate attenuation of this effect at the highest concentration of 64 µM (p<0.01, p=0.03, and 227 
p=0.04, respectively). For islet size in 96 hpf eleutheroembryos, a similar non-monotonic, U-228 
shaped response was observed. As at the earlier developmental stage, the most severe decrease of 229 
islet area was observed in the eleutheroembryos exposed to 32 µM PFOS (p<0.01).  230 
 231 
ISLET MORPHOLOGY 232 
 To observe whether PFOS exposures could produce anomalous islet morphology in 233 
addition to decreased islet areas, embryos and larvae were examined for morphological variants 234 
of the primary islet at 48, 96, and 168 hpf. Normally, islets are spherical, compact, and located 235 
near the 4th somite after 24 hpf. We previously identified several examples of anomalous islet 236 
morphology from toxicological perturbation with PCB-126, including islet fragmentation, 237 
ectopic beta cells, and hypomorphic islets (Timme-Laragy et al., 2015). Here, we also observed 238 
these morphologies as well as several newly identified variants due to PFOS exposures. The 239 
prevalence of total islet malformations was elevated in embryos and larvae at all time points for 240 
all PFOS exposure concentrations respective to controls (Fig. 2A). The distribution of 241 
morphologies was also time sensitive (Fig. 2B). At 48 hpf, 16, 32, and 64 µM PFOS significantly 242 
increased the incidence of anomalous morphologies (p=0.05, p<0.01, and p<0.01, respectively), 243 
primarily due to an increased number of stunted islets, which appear as a thin row of beta cells 244 
rather than a spherical mass. At 96 hpf, the frequency of total islet variants more than doubled 245 
for all PFOS exposures due to increased incidence of islets that appeared hollow/ring-shaped or 246 
fragmented, though these changes were not statistically significant (p>0.05). At 168 hpf, PFOS 247 
increased islet variant frequency for 16 (p>0.05), and especially 32 and 64 µM exposures 248 
(p=0.01 and p=0.04), and hollow islet morphology was the most commonly observed variant. 249 
 250 
SECONDARY ISLETS 251 
The mature pancreas has many secondary islets throughout the length of its entire tissue, 252 
which begin to appear in zebrafish between 5-7 dpf. The number of secondary islets in the 253 
pancreas and timing of their development can be sensitive to pharmacological stimuli (Wang et 254 
al., 2015). To assess whether PFOS alters the timing of secondary islet formation, the number of 255 
larvae with secondary islets was quantified for all PFOS exposures (Fig. 3). Approximately 40% 256 
of control larvae developed at least one secondary islet at 168 hpf. Compared to controls, the 257 
number of PFOS-exposed larvae with secondary islets decreased following the same U-shaped, 258 
non-monotonic response as observed with islet area. Larvae exposed to 32 µM were more than 259 
59% less likely to have begun developing secondary islets than controls (p=0.04), though there 260 
were no significant differences between controls and 16 or 64 µM PFOS exposed larvae.  261 
FISH GROWTH 262 
Endocrine disruption is often coupled with perturbations in developmental growth and 263 
metabolic programming. Therefore, fish length at 168 hpf was measured to determine whether 264 
the concentrations of PFOS exposure used in this study altered the overall growth of the embryos 265 
and larvae (Fig. S1). Total fish length was unchanged in larvae exposed to 16 µM PFOS. Larvae 266 
exposed to 32 µM (p=0.07) and 64 µM PFOS were 2% (p<0.01) and 1.5% (p=0.07) smaller, 267 
respectively. We observed no mortality. Because several other studies examined embryotoxicity 268 
of PFOS in zebrafish and observed increased incidence of delayed swim bladder inflation and 269 
spinal lordosis, we assessed these outcomes at 96 and 168 hpf respectively (Supplemental Table 270 
2). There was a slight decrease in the percent of eleutheroembryos with inflated swim bladders at 271 
96 hpf and an increase in the number of eleutheroembryos with lordosis at 168 hpf, though none 272 
of these differences were statistically significant. 273 
 274 
PANCREAS LENGTH 275 
The pancreas is predominantly composed of exocrine tissue, which lengthens in the 276 
posterior direction between 48-96 hpf during zebrafish development. Though primary islets form 277 
in the region proximal to the gut (pancreas head), greater concentrations of secondary islets 278 
develop throughout the distal body and tail regions of the pancreas once exocrine extension has 279 
completed (Elayat et al., 1995; Wang et al., 2013; Wittingen and Frey, 1974). Pancreas length 280 
has been inversely associated with incidence of diabetes in adulthood (Agabi and Akhigbe, 281 
2016), likely due to the shortening of the islet-dense regions. Here, we wanted to observe 282 
whether these shortened pancreases could be observed during development and whether 283 
toxicological perturbation may contribute to this phenotype. Pancreas extension was observed at 284 
96 and 168 hpf, and the length from the center of the primary islet to the posterior tip of the 285 
exocrine pancreas was measured in ptf1a transgenic fish (Fig. 4A). Pancreas length was 286 
decreased by 7-20% at 96 hpf and by 1-7% at 168 hpf, both following the characteristic U-287 
shaped non-monotonic dose-response curve observed in our other measures (Fig. 4B). Pancreas 288 
length was significantly decreased in 96 hpf eleutheroembryos exposed to 32 and 64 µM PFOS, 289 
with the greatest decrease occurring with exposure to 32 µM (p=0.01 and p=0.04, respectively). 290 
At 168 hpf, only larvae exposed to 32 µM PFOS showed significant reduction of pancreas length 291 
compared to controls compared to controls (p=0.04). The relative pancreas length was calculated 292 
for each fish (pancreas length/fish length) to identify any associations between pancreas and total 293 
body growth (Fig. S2). There were no significant changes in relative pancreas length due to 294 
PFOS exposures, though there was a subtle, linear, dose-dependent decrease. 295 
 296 
 297 
ENDOCRINE GENE EXPRESSION 298 
Because PFOS produced structural changes of the developing pancreas in our embryos 299 
and larvae, gene expression of endocrine pancreatic hormones and transcription factors was 300 
quantified to observe whether any functional changes were produced by PFOS exposures. Here, 301 
we quantified gene expression of several major hormones and endocrine transcription factors. 302 
Insulin (Insa) is secreted by beta cells and stimulates the uptake of glucose from the blood into 303 
tissues. Glucagon a (Gcga), the hormone stimulating breakdown of glucose stores into free 304 
glucose, is secreted from islet alpha cells and often has an inverse relationship with insulin. 305 
Somatostatin 2 (Sst2) belongs to a family of genes with a myriad of endocrinology roles, 306 
including inhibition of insa expression, and is secreted from delta cells. Ghrelin (Ghrl), also an 307 
inhibitor of insa expression, is produced in hunger conditions by the islet epsilon cells and 308 
functions to counteract the action of the anorexic hormone leptin (produced by fat cells) in the 309 
brain. Pancreatic and duodenal homeobox 1 (Pdx1) is an endocrine pancreas-specific 310 
transcription factor that governs the expression of glucoregulatory genes, including insa. 311 
Together, these hormones and factors help govern endocrine function and glucose homeostasis 312 
for the entire organism. 313 
Exposure to PFOS disrupted expression of genes which govern the glucoregulatory 314 
hormone axis in islet cells. At 48 hpf, islet sizes and insa expression were not concordant, since 315 
gene expression was unchanged by treatment. However, at 96 hpf, eleutheroembryos exposed to 316 
32 and 64 µM PFOS had reduced insa expression compared to controls at 96 hpf (p<0.01 and 317 
p=0.05, respectively), which was concordant with islet size data (Fig. 5A). Expression of gcga 318 
was relatively stable at both 48 and 96 hpf (Fig. 5B), but exposure to 64 µM PFOS nearly 319 
doubled expression (p=0.01) at 96 hpf. Expression of transcription factor pdx1 also nearly 320 
doubled following 64 µM PFOS exposure in 96 hpf eleutheroembryos (p<0.01) compared to 321 
controls (Fig. 5C), and was also significantly decreased by 32 µM PFOS exposure in 48 hpf 322 
embryos (p=0.04).  323 
Expression of sst2 was decreased by more than 20% in 48 hpf embryos exposed to 32 324 
µM PFOS (p=0.05; Fig. 5D). All PFOS exposures significantly decreased sst2 expression in 96 325 
hpf eleutheroembryos compared to controls (p<0.01 for all concentrations), and followed a non-326 
monotonic U-shaped response curve. Ghrelin expression was sensitive to PFOS exposures at 327 
both 48 and 96 hpf (Fig. 5E). Exposures of 16, 32, or 64 µM PFOS significantly decreased ghrl 328 
expression in embryos by nearly 50% (p=0.03, p<0.01 and p<0.01, respectively). This same 329 
response was observed at 96 hpf, with the 16 and 64 µM exposures halving ghrl expression 330 
(p<0.01) and the 32 µM exposure decreasing expression by over 70% (p<0.01). 331 
 332 
EXOCRINE GENE EXPRESSION 333 
 Both the endocrine and exocrine pancreas play important roles in glucose homeostasis, 334 
either through the secretion of glucoregulatory hormones into the vasculature or of digestive 335 
peptides. Since pancreas length was shortened, as quantified by measuring the length of the 336 
exocrine pancreas, we wanted to assess whether these structural changes co-occurred with gene 337 
expression alterations that may be crucial for exocrine pancreas development and function. 338 
Likewise, this would allow us to examine whether the effects of PFOS are specific to only the 339 
endocrine pancreas. Expression of these genes was only characterized at 96 hpf, due to the lack 340 
of exocrine architecture in the embryonic pancreas at 48 hpf. First, expression of transcription 341 
factor ptf1a was assessed to determine whether the altered exocrine pancreas structure, as 342 
visualized by using the Tg(ptf1a-GFP) transgenic line, is correlated with ptf1a gene expression 343 
(Fig. 6A). While an increasing trend was observed, there was no significant change in ptf1a 344 
expression.  345 
We also measured expression of several digestive enzymes synthesized in the exocrine 346 
pancreas. The dose-dependent expression profiles of the proteases trypsin (try, Fig. 6B) and 347 
chymotrypsinogen B1 (ctrb1, Fig. 6C) were similar. Expression of try decreased at the 16 µM 348 
(p=0.06) and 32 µM concentrations, though was only statistically significant for the 32 µM 349 
concentration (p<0.01). Expression of ctrb1 was significantly decreased at both the 16 and 32 350 
µM PFOS concentrations (p=0.02 and p=0.01, respectively). For both proteases, the effect was 351 
attenuated for the 64 µM treated eleutheroembryos. We also examined the expression of the 352 
carbohydrate digestive enzyme amy2a, the form of amylase produced by the exocrine pancreas 353 
(Fig. 6D). Expression of amy2a was also decreased by both the 16 µM (p=0.06) and 32 µM 354 
PFOS exposures, though only significantly for the 32 µM concentration (p<0.01). Also similar to 355 
the other proteases, this effect was attenuated in the embryos exposed to 64 µM. 356 
 357 
DISCUSSION 358 
Incidence of diabetes and metabolic syndrome, especially among children, has been 359 
rapidly increasing in the United States, presenting an emerging public health and economic crisis 360 
(D’Adamo and Caprio, 2011; Dabelea et al., 2014; Li et al., 2009; Silverstein et al., 2005). 361 
Though genetics and lifestyle are well known to increase risk for these disorders, the 362 
contribution of the chemical environment is not well understood. To better understand the 363 
contributions of environmental toxicant exposures to the developmental origins of diabetes, we 364 
investigated the health consequences of PFOS on organogenesis of the pancreas, an organ central 365 
to digestive function and glucoregulation. We also propose new developmental criteria to 366 
contribute to an AOP framework for the developmental origins of metabolic dysfunction using 367 
the zebrafish model. Pancreatic organogenesis is a highly conserved process across vertebrates; 368 
zebrafish are an ideal model for these studies due to the rapid development of transparent 369 
embryos and availability of transgenic models which enable in vivo observation of the 370 
developing pancreas in real time. Thus, we are able to quantify the effect of contaminants 371 
directly in the pancreas of living vertebrate embryos. In this study, we investigated whether 372 
embryonic exposure to the ubiquitous contaminant PFOS may disrupt pancreas development.  373 
We observed increased incidence of hypomorphic and defective islets in PFOS-exposed 374 
embryos and larvae compared to controls (Figs. 1 and 2). Since islet size and architecture have 375 
been associated with both Type 1 and Type 2 diabetes, this data suggests that developmental 376 
PFOS could increase risk for diabetes later in life. These observed morphologies, coupled with a 377 
matching dose-response for hormone gene expression, suggest that the acute effects of PFOS 378 
exposures during early development are likely to result in insulin deficiency. In this study, 379 
Tg(ins:gfp) zebrafish were used to visualize islet architecture, specifically beta cells. We 380 
observed altered size and morphology, but we cannot attribute this decrease to fewer beta cells. 381 
In future work we will quantify whether the perturbations observed in this study translate to 382 
decreased numbers of beta cells and/or impact the architecture, or influence other islet cell types 383 
such as alpha cells. 384 
With respect to the endocrine pancreas, we observed a similar dose response for many of 385 
our morphological and gene expression endpoints. The high degree of concordance between 386 
these endpoints suggests that pancreas morphologies and hormones might be predictive of each 387 
other during embryonic development. If so, these measures could be utilized in an AOP 388 
framework for understanding embryonic contributions to diabetes. Further, exocrine pancreas 389 
endpoints such as pancreas length and digestive peptide expression also followed a U-shaped 390 
dose-response when exposed to the same PFOS concentrations. This also suggests that 391 
developmentally susceptible windows of the endocrine and exocrine pancreas tissues may be 392 
similar. 393 
Expression of insa was intially lowered by PFOS exposures, but attenuated by the highest 394 
concentration (Fig. 5). This attenuation was complemented by nearly doubled expression of pdx1 395 
and gcga at 96 hpf. These data suggest that this increased pdx1 expression might directly 396 
increase the expression of insa and gcga since pdx1 serves as a transcription factor for the two 397 
hormones. It is possible that this increase of pdx1 expression causes the attenuation of islet 398 
effects at the highest PFOS concentration for all of the islet morphology and gene expression 399 
data, and future study of causality is necessary. The mechanism by which pdx1 is induced by 400 
PFOS exposure warrants further research, though it has been shown to be sensitive to oxidative 401 
stress (Harmon et al., 2005; Hoarau et al., 2014; Kaneto et al., 1999). PFOS has been repeatedly 402 
demonstrated to induce oxidative stress across a variety of tissues and model organisms, 403 
including the zebrafish embryo (Chen et al., 2012; Hu et al., 2005; Liu et al., 2007; Shi and 404 
Zhou, 2010). More work is required to explore the mechanisms by which oxidative stress may 405 
influence these signaling pathways. 406 
PFOS exposures increased the incidence of variant islets throughout development. 407 
Exposures produced the greatest percentage of islet variants at 48 hpf, and these percentages 408 
decreased until 7 dpf (Fig. 2). The decreasing percentage of islet variants suggests that either 409 
these morphologies are not completely persistent or that compensation may occur. In particular, 410 
the zebrafish has a greater regenerative capacity compared to humans. In this study, we utilized a 411 
repeated daily PFOS exposure in order to minimize regenerative time and more closely mimic a 412 
constant exposure produced by the human in utero environment. The incidence of variants 413 
observed in the same population decreased between 2-7 dpf by 50-80%. Juvenile and adult 414 
zebrafish could be used to study the resilience and sensitivity of beta cells during specific 415 
windows of the lifecourse. 416 
We have identified specific morphological islet variants during development. Because 417 
pancreatic malformations have been associated with increased risk for diabetes, understanding 418 
the causes and consequences of these anomalies could help us to improve and expand an AOP 419 
for developmental contributions to diabetes and other pancreatic diseases (Balakrishnan et al., 420 
2006; Concepcion et al., 2014; Gentile and Fiorente, 1999; Gilinsky et al., 1987; Lindstrom et 421 
al., 1990; Mitchell et al., 2004; Shoji et al., 2013). The prevalence of these morphological 422 
variants within the control group suggests that there is some innate variability in these 423 
developmental processes regardless of exposures, as we have recently shown (Sant et al., 2016). 424 
The background prevalence of these variants in our controls of 3-8% falls within the estimated 425 
background rate for humans based upon clinical data (Prasad et al., 2001; Varshney and Johnson, 426 
1999; Vaughn et al., 1998). The variants observed in this study appear to be morphologically 427 
congruent to developmental anomalies observed in humans, suggesting that the zebrafish may be 428 
an appropriate model organism for studying and understanding human congenital pancreatic 429 
defects.  430 
We have shown that PFOS exposures during organogenesis may alter the length of the 431 
pancreas (Fig. 4), a measure associated with diabetic phenotypes in humans. To our knowledge, 432 
this is the first study to causally link embryonic exposures with congenitally shortened pancreas. 433 
Because the majority of islets are eventually concentrated in the distal body and tail regions of 434 
the pancreas, it is possible that a shortened pancreas could reduce the number of total islets due 435 
to loss of habitable area. Dorsal pancreatic agenesis, the partial or complete lack of a pancreatic 436 
tail, is uncommon, but rarely diagnosed due to the mild phenotypic consequences. The zebrafish 437 
provides an excellent model to test for the relationship between pancreas length and metabolic 438 
dysfunction, as the pancreas can be easily imaged in the living organism. Because of the novelty 439 
of this finding, more work is necessary to understand the types of compounds that could affect 440 
pancreas length, and the mechanisms by which they may act. 441 
In this study, pancreas length was observed using ptf1a transgenic zebrafish, where green 442 
fluorescence is present throughout their exocrine pancreas. To validate these findings, we also 443 
analyzed ptf1a gene expression. Unexpectedly, ptf1a expression was not significantly changed 444 
and did not follow the same U-shaped response observed for pancreas length. Instead, there is an 445 
increasing trend for ptf1a gene expression (Fig. 6). Though this data did not confirm the exocrine 446 
pancreas length dose-response, ptf1a is not a pancreas-restricted transcription factor, and isan 447 
important transcription factor in the central nervous system (Aldinger and Elsen, 2008; Kani et 448 
al.; Pashos et al., 2013; Sellick et al., 2004). The hindbrain expression of ptf1a was visible in our 449 
embryo model (Fig. 4A). Because gene expression was quantified using whole embryos instead 450 
of pancreas tissue alone, the contribution of these other tissues may be confounding this data and 451 
therefore, ptf1a may not be a good candidate for an AOP framework. 452 
Though the pancreas length decreased, we also characterized gene expression of several 453 
digestive enzymes to better understand whether the observed exocrine pancreas structure was 454 
associated with altered exocrine function. Expression of proteases try and ctrb1 as well as of the 455 
glycolytic enzyme amy2a was decreased by 16 and 32 µM PFOS exposures; however, this effect 456 
was attenuated by 64 µM PFOS exposure (Fig. 6). Though this dose-response does follow along 457 
with pancreas length, it was interesting that the high-dose PFOS exposure was unable to produce 458 
the structural and expression changes observed at lower concentrations. Further work should 459 
investigate whether PFOS alters the uptake, distribution, and utilization of nutrients during 460 
organogenesis, since these factors have been implicated in the developmental origins of diseases 461 
such as diabetes. 462 
This work provides several developmental outcomes of PFOS exposure in the pancreas. 463 
However, the contributions of these pancreatic variants to overall developmental progress and 464 
growth remain unknown. Here, a modest decrease of total larval length was measured due to 465 
PFOS exposure. Though a 2% decrease of fish length is a mild phenotypic change, it is not 466 
insignificant. In the United States, there is only a modest 4-6% difference in fetal length between 467 
the median infant length and fetuses small for gestational age, defined as the lowest 10th 468 
percentile for fetal growth (Fenton and Kim, 2013). A longitudinal study should be performed to 469 
observe whether these pancreas morphologies and physiological consequences persist beyond 470 
early developmental stages, or whether juvenile or adult fish are able to “catch up” and correct 471 
for previous deficiencies. It is important to identify whether these developmental consequences 472 
will ultimately manifest as metabolic dysfunction throughout the lifecourse in order to better 473 
define prenatal parameters for interrogation in a developmental origins of diabetes AOP.  474 
There are many gaps in our understanding of an AOP for the development of diabetes 475 
produced by early life exposures. Numerous studies have examined epidemiological associations 476 
between developmental exposures and metabolic dysfunction, or the pathological consequences 477 
of toxicant exposures on adult beta cells. However, pancreas teratogenesis has rarely been 478 
studied, but may provide a link between the embryonic biochemical and molecular changes and 479 
the pathological outcomes later in life. In this study, we have addressed several of these gaps by 480 
elucidating changes in gene expression and signaling, as well as structural anomalies in the 481 
embryonic pancreas (Fig. 7, shown in bold). Future studies will further investigate the 482 
mechanistic basis of these structural changes, and how they manifest as metabolic dysfunction 483 
throughout the lifecourse. 484 
 485 
CONCLUSION 486 
 In conclusion, we have identified specific morphological and likely functional 487 
consequences of PFOS-induced perturbation of pancreatic organogenesis in both endocrine and 488 
exocrine tissues for the purpose of expanding and improving an AOP. This work establishes a 489 
foundation for future toxicology studies of the developing pancreas. We seek to establish a 490 
predictive AOP framework for understanding the embryonic contributions to diabetes risk 491 
through studying the mechanisms by which these morphological consequences may increase risk 492 
for diabetes later in the lifecourse. In the future, we will continue to pursue the coordinated 493 
characterization of the pancreatic biochemical, molecular, and morphological consequences of 494 
toxicological perturbations during these newly identified key windows of developmental 495 
susceptibility.  496 
 497 
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  699 
FIGURE CAPTIONS 700 
Fig 1. PFOS decreases islet area at 48 and 96 hpf. Islet area was measured in Tg(insulin-GFP) 701 
embryos using EVOS software. Islet area was decreased along a U-shaped curve. Asterisks (*) 702 
indicate a difference between designated treatment group and the controls (p<0.05); n=30-45 703 
embryos at 48 hpf; n=20-25 eleutheroembryos at 96 hpf 704 
 705 
Fig 2. PFOS exposure increases the frequency of anomalous pancreas morphologies during 706 
development. (A) Islet morphology was examined in Tg(insulin-GFP) transgenic fish at 48, 96, 707 
and 168 hpf after subchronic PFOS exposure beginning at 3 hpf. Islets were screened for 708 
fragmentation, hollowness, and severely stunted growth (shown in B at 20x magnification). 709 
Numbers presented are the percent of embryos/larvae with variant islets. Italicized numbers are 710 
the number of embryos/larvae sampled, cumulative across several study replicates. Fewer than 711 
5% of embryos and larvae were severely deformed at the time of sampling, and were excluded 712 
from pancreas imaging. The distribution of islet morphologies are shown in pie charts under each 713 
respective time point, indicating a difference in the types of variants observed throughout 714 
development. No significant temporal differences were observed. The position of the islet within 715 
the zebrafish is shown (B, left). Asterisks (*) indicate a difference between designated treatment 716 
group and the controls (p<0.05); n=30-45 embryos at 48 hpf; n=20-25 eleutheroembryos at 96 717 
hpf; n=24-29 larvae at 168 hpf 718 
 719 
Fig 3. PFOS exposure delays formation of secondary islets. (A) Secondary islets are 720 
characterized by one or more beta cells developing after the primary islet (arrow), typically after 721 
120 hpf. (B) The number of secondary islets at 7 dpf was quantified in Tg(insulin-GFP) larvae. 722 
Incidence of islet defects was 19/47 (40%) in controls, 9/36 (25%) in the 16 µM group, 6/36 723 
(17%) in the 32 µM group, and 13/43 (30%) in the 64 µM group. Bars represent the percent of 724 
larvae with secondary islets. Asterisks (*) indicate a difference between designated treatment 725 
group and the controls (p<0.05); n=36-47 larvae per group.  726 
 727 
Fig 4. PFOS exposure decreases exocrine pancreas length at 96 and 168 hpf. (A) Pancreas length 728 
was measured in Tg(ptf1a-GFP) transgenic fish, shown at 168 hpf. Pancreas length was 729 
measured by quantifying the distance from the center of the islet (arrow) to the posterior tail of 730 
the pancreas. A control pancreas of normal length is shown at left, and a PFOS-exposed and 731 
shortened pancreas is shown at right. (B) Pancreas length is significantly decreased in fish 732 
exposed to 32 and 64 µM PFOS at 96 hpf, and to 32 µM PFOS at 168 hpf.  Asterisks (*) indicate 733 
a difference between designated treatment group and the controls (p<0.05); n=22-28 larvae 734 
 735 
Fig 5. Embryonic PFOS exposure alters pancreas endocrine gene expression. RNA was isolated 736 
from embryos collected at 48 and 96 hpf, following subchronic PFOS exposure since 3 hpf. 737 
Expression of insa (A), gcga (B), pdx1 (C), sst2 (D), and ghrl (E) was analyzed using qPCR and 738 
the ΔΔCT method. Bars represent the average fold change (relative to beta actin; shown on y-739 
axis) and the control group, and stars represent a PFOS-associated statistically significant change 740 
of expression from the control group. Age of the embryos and eleutheroembryos is shown on the 741 
x-axis in hpf. Asterisks (*) indicate a difference between designated treatment group and the 742 
controls (p<0.05); n=7-9 samples of 9 pooled embryos at 48 hpf; n=4-5 samples of 5 pooled 743 
eleutheroembryos at 96 hpf 744 
 745 
Fig 6. Embryonic PFOS exposure alters pancreas exocrine gene expression. RNA was isolated 746 
from 96 hpf following subchronic PFOS exposure since 3 hpf. Expression of ptf1a (A), try (B), 747 
ctrb1 (C), and amy2a (D) was analyzed using qPCR and the ΔΔCT method. Bars represent the 748 
average fold change (relative to beta actin; shown on y-axis) and the control group, and stars 749 
represent a PFOS-associated statistically significant change of expression from the control group. 750 
Asterisks (*) indicate a difference between designated treatment group and the controls (p<0.05); 751 
n=4-5 samples of 5 pooled eleutheroembryos at 96 hpf 752 
 753 
Fig 7. This study helps to expand an AOP framework for the developmental origins of metabolic 754 
dysfunction and diabetes. Findings of this study (highlighted in black boxes) provide new criteria 755 
for use in an AOP framework for the association between developmental exposures and 756 
metabolic dysfunction. This framework (flowing from left to right) has guided the identification 757 
of several key biochemical, molecular, cellular, and organ changes that lead to these disorders; 758 
however, the effects of exposures such as PFOS on pancreas structure had not been studied. In 759 
the future, we seek to elucidate a mechanism by which these exposures may cause 760 
dysmorphogenesis of the endocrine and exocrine pancreas, and further how these structural 761 
anomalies are associated with the development of metabolic dysfunction later in the lifecourse. 762 
 763 
Supplemental Figure 1. Embryonic PFOS exposures affect overall fish growth. Fish length at 764 
168 hpf was not affected in the 16 or 64 µM exposure groups, though a significant decrease in 765 
fish length was observed in those exposed to 32 µM PFOS (p<0.01). Asterisks (*) indicate a 766 
difference between designated treatment group and the controls (p<0.05); n=24-30 larvae 767 
 768 
 769 
Supplemental Figure 2. Embryonic PFOS exposures produce only a modest change in the 770 
relative lengths of the pancreas. There is a linear, dose-dependent decrease in the relative length 771 
of the pancreas (pancreas length/total larval length), though this change is not statistically 772 
significant. n=24-30 larvae 773 
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 776 
Supplemental Table 1. Quantitative PCR primer sequences. 777 
Gene 
Forward primer (5’-3’) 
Tm Reference Reverse primer (5’-3’) 
actb 
CAACAGAGAGAAGATGACACAGATCA 
65 Evans et al., 2005 
GTCACACCATCACCAGAGTCCATCAC 
b2m 
CTGAAGAACGGACAGGTTATGT 
58   
ACGCTGCAGGTATATTCATCTC 
insa 
GCCCAACAGGCTTCTTCTACAAC 
63 Wilfinger et al., 2013 
GCAGATTTAGGAGGAAGGAAACCC 
 778 
 779 
Supplemental Table 2. Observed embryo deformities following PFOS exposures. 780 
Exposure 
 
% Inflated Swim Bladder 
 (96 hpf) 
% Spinal Deformities 
(168 hpf) 
Control (DMSO) 83% 4% 
PFOS (16 µM) 77% 22% 
PFOS (32 µM) 75% 28% 
PFOS (64 µM) 78% 28% 
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